Related Experiment Video

Updated: Jul 15, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Peptide-based immunotherapeutic approaches to glioma: a review

Ryuya Yamanaka1, Kyogo Itoh

  • 1Kurume University School of Medicine, Research Center of Innovative Cancer Therapy, Asahimachi 67, Kurume, Fukuoka 830-0011, Japan. ryaman@med.kurume-u.ac.jp

Expert Opinion on Biological Therapy
|May 5, 2007
PubMed

Insights

Malignant glioma patients have a poor prognosis. Peptide-based immunotherapy offers a promising new treatment approach, potentially inducing antitumor responses and prolonging survival with minimal side effects.

Area of Science:

  • Neuro-oncology
  • Immunotherapy
  • Cancer Research

Background:

  • Malignant glioma prognosis remains poor despite conventional treatments like surgery, radiation, and chemotherapy.
  • There is a critical need for novel therapeutic strategies to improve patient outcomes.

Purpose of the Study:

  • To explore peptide-based immunotherapy as a potential novel treatment modality for malignant glioma.
  • To evaluate the efficacy of immunotherapy in inducing an antiglioma response and prolonging survival.

Main Methods:

  • Review of existing reports on systemic immunotherapy, including dendritic cell and peptide vaccines.
  • Analysis of the potential of peptide-based strategies in inducing antitumor immune responses.

Main Results:

  • Systemic immunotherapy, particularly peptide vaccines, has shown potential in eliciting antiglioma responses.
  • Peptide-based immunotherapy strategies demonstrate promise in prolonging survival in glioma patients.

Conclusions:

  • Peptide-based immunotherapy represents a promising new treatment modality for brain tumors, including malignant glioma.
  • This approach may offer a way to induce antitumor immune responses and improve survival with fewer side effects.

More Related Videos

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations04:46

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...